Table 6

Cost-effectiveness sensitivity (A) and subgroup analysis (B)

Intervention group (n)Control group (n)Cost of intervention (£)ICER (£)Bootstrapped one-sided 95% CI for ICER (£)Probability that intervention is cost effective*
(A) Sensitivity analyses
 Base case39539138512 11158 88189%
 Mean intervention and control EQ-5D at 6 months as estimate of baseline395391385605537 15996%
 Control group mean EQ-5D value at 6 months as estimate of baseline395391385710924 85398%
 Participant payment of £1 per session395391385–32=35310 92669 08591%
 Participant payment of £2 per session395391385–64=321974164 63892%
Intervention group (n)Control group (n)Incremental cost (bootstrapped 95%CI)Incremental QALY (bootstrapped 95%CI)ICER (bootstrapped one-sided 95%CI)
(B) Subgroup analysis
 Referral reason
  CHD only307309£239 (−51 to 547)0.0183 (−50.0047 to 0.0416)£13 060 (117 893)
  Mental health (MH) and MH plus CHD8076£596 (−5304 to 1616)0.058 (0.017 to 0.100)£10 276 (50 925)
 Gender
  Male135130£322 (−5180 to 792)0.0084 (–0.0250 to 0.0400)£38 333 (254 973)
  Female265268£326 (−589 to 761)0.0362 (0.0111 to 0.0623)£9006 (390 00)
 Age
  <44 years6971£68 (−5462 to 678)0.0656 (0.0137 to 0.1148)£1037 (16 418)
  44–60 years135136£577 (−5176 to 1373)0.0179 (−0.0194 to 0.0561)£32 235 (314 108)
  >60 years196191£244 (−5131 to 586)0.0187 (−0.0057 to 0.0424)£13 048 (153 565)
 Adherence
  0 weeks30£1785 (25 to 4570)−0.0114 (−0.0680 to 0.0390)NA
  <16 weeks123£662 (212 to 1157)−0.0084 (−0.0384 to 0.0218)NA
  16 weeks247–£18 (−5310 to 277)0.049 (0.0277 to 0.0706)−£367 (7068)
  • * At the £30 000 per QALY threshold.

  • EQ5D, EuroQol—5 Dimensions; ICER, incremental cost-effectiveness ratio; QUALY, quality adjusted life year.